Federal Contractor Profile
Ministry Of Defence
Federal contracting record: $116M obligated across 69 awards from 3 agencies, FY 2016–2026.
Company Profile
Parent UEI (Unique Entity Identifier)
YR2NLK6FP5B1
CAGE Code
KB887
Registered Entities (UEIs)
4 under this organization
Address
D S T L ROOM 1, BUILDING 352, SALISBURY, SP4 00000
First Federal Award
Oct 1, 2015
Most Recent Award
Jul 29, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Defense$99M
85.7% of total obligations
- Department of Health and Human Services$16M
14.0% of total obligations
- Department of Energy$400K
0.3% of total obligations
Top NAICS Activity
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| May 19, 2026 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $240K |
| May 18, 2026 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $2.0M |
| Jan 22, 2026 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $650K |
| Jan 7, 2026 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $1.5M |
| Aug 5, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $400K |
| Jul 30, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $779K |
| Jun 11, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $221K |
| May 15, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $104K |
| Mar 6, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $186K |
| Feb 19, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $386K |
| Feb 13, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $713K |
| Feb 6, 2025 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $245K |
| Sep 17, 2024 | Department of DefenseNAVAL AIR SYSTEMS COMMAND | 336413 | CWB KITS & SHIPPING FIXTURE | $9.1M |
| Sep 10, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $232K |
| Jun 25, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $125K |
| Jun 11, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $99K |
| Jun 6, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $535K |
| Apr 18, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $1.4M |
| Mar 4, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $75K |
| Jan 10, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $125K |
| Nov 8, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $1.3M |
| Sep 25, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $86K |
| Aug 14, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $205K |
| Aug 1, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $154K |
| Jul 28, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $608K |
Want to win work like Ministry Of Defence?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.